Myopathy with Ezetimibe Monotherapy;Statin-Associated Pancreatitis;Linezolid Associated Toxic Optic Neuropathy;Hiccups and Dopamine Agonists;SIADH and Seizures in a Patient Treated with Duloxetine;Prevention of a Well-Known Adverse Drug Reaction
Restricted accessResearch articleFirst published online May, 2006
Myopathy with Ezetimibe Monotherapy;Statin-Associated Pancreatitis;Linezolid Associated Toxic Optic Neuropathy;Hiccups and Dopamine Agonists;SIADH and Seizures in a Patient Treated with Duloxetine;Prevention of a Well-Known Adverse Drug Reaction
The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the FDA's medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.
Get full access to this article
View all access options for this article.
References
1.
HavranekJ.M., WolfsenA.R., WarnkeG.A., PhillipsP.S.Monotherapy with ezetimibe causing myopathy. Am J Med.2006; 119: 285–286.
2.
JohnsonJ.L., LoomisI.B.A case of simvistatin-associated pancreatitis and review of statin-associated pancreatitis. Pharmacotherapy.2006; 26: 414–422.
3.
ShusterJ.ISMP adverse drug reactions. Hosp Pharm.2005; 40: 384.
4.
ShusterJ.ISMP adverse drug reactions. Hosp Pharm.2004; 39: 407.
